[1] |
GRESSE R, CHAUCHEYRAS-DURAND F, FLEURY M A, et al. Gut microbiota dysbiosis in postweaning piglets:understanding the keys to health[J]. Trends Microbiol, 2017, 25(10):851-873.
|
[2] |
MORRISETTE T, KEBRIAEI R, LEV K L, et al. Bacteriophage therapeutics:a primer for clinicians on phage-antibiotic combinations[J]. Pharmacotherapy, 2020, 40(2):153-168.
|
[3] |
DALMASSO M, HILL C, ROSS R P. Exploiting gut bacteriophages for human health[J]. Trends Microbiol, 2014, 22(7):399-405.
|
[4] |
REHMAN S, ALI Z, KHAN M, et al. The dawn of phage therapy[J]. Rev Med Virol, 2019, 29(4):e2041.
|
[5] |
MIRZAEI M K, MAURICE C F. Ménage à trois in the human gut:interactions between host, bacteria and phages[J]. Nat Rev Microbiol, 2017, 15(7):397-408.
|
[6] |
OFIR G, SOREK R. Contemporary phage biology:from classic models to new insights[J]. Cell, 2018, 172(6):1260-1270.
|
[7] |
UL HAQ I, CHAUDHRY W N, AKHTAR M N, et al. Bacteriophages and their implications on future biotechnology:a review[J]. Virol J, 2012, 9:9
|
[8] |
MAHMOUD M, ASKORA A, BARAKAT A B, et al. Isolation and characterization of polyvalent bacteriophages infecting multi drug resistant Salmonella serovars isolated from broilers in Egypt[J]. Int J Food Microbiol, 2018, 266:8-13.
|
[9] |
PARK M, LEE J H, SHIN H, et al. Characterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7[J]. Appl Environ Microbiol, 2012, 78(1):58-69.
|
[10] |
SAMBROOK J, RUSSELL D W. 分子克隆实验指南[M]. 黄培堂, 译. 3版. 北京:科学出版社, 2002:185-187, 195-197.SAMBROOK J, RUSSELL D W. Molecular cloning:a laboratory manual[M]. HUANG P T, trans. 3rd ed. Beijing:Science Press, 2002:185-187, 195-197. (in Chinese)
|
[11] |
KUTTER E. Phage host range and efficiency of plating[J]. Methods Mol Biol, 2009, 501:141-149.
|
[12] |
KHAN MIRZAEI M, NILSSON A S. Isolation of phages for phage therapy:a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy[J]. PLoS One, 2015, 10(3):e0118557.
|
[13] |
ABEDON S T. Lysis from without[J]. Bacteriophage, 2011, 1(1):46-49.
|
[14] |
OECHSLIN F. Resistance development to bacteriophages occurring during bacteriophage therapy[J]. Viruses, 2018, 10(7):351.
|
[15] |
CHEN M M, ZHANG L, XIN S P, et al. Inducible prophage mutant of Escherichia coli can lyse new host and the key sites of receptor recognition identification[J]. Front Microbiol, 2017, 8:147.
|
[16] |
HYMAN P, ABEDON S T. Bacteriophage host range and bacterial resistance[J]. Adv Appl Microbiol, 2010, 70:217-248.
|
[17] |
ROSTØL J T, MARRAFFINI L. (Ph)ighting phages:how bacteria resist their parasites[J]. Cell Host Microbe, 2019, 25(2):184-194.
|
[18] |
LOPEZ PASCUA L, HALL A R, BEST A, et al. Higher resources decrease fluctuating selection during host-parasite coevolution[J]. Ecol Lett, 2014, 17(11):1380-1388.
|
[19] |
MERCANTI D J, ACKERMANN H W, QUIBERONI A. Characterization of two temperate Lactobacillus paracasei bacteriophages:morphology, kinetics and adsorption[J]. Intervirology, 2015, 58(1):49-56.
|
[20] |
LUKMAN C, YONATHAN C, MAGDALENA S, et al. Isolation and characterization of pathogenic Escherichia coli bacteriophages from chicken and beef offal[J]. BMC Res Notes, 2020, 13(1):8.
|
[21] |
HUANG C X, SHI J C, MA W J, et al. Isolation, characterization, and application of a novel specific Salmonella bacteriophage in different food matrices[J]. Food Res Int, 2018, 111:631-641.
|
[22] |
SHARMA M. Lytic bacteriophages:Potential interventions against enteric bacterial pathogens on produce[J]. Bacteriophage, 2013, 3(2):e25518.
|
[23] |
GÓRSKI A, WEBER-DABROWSKA B. The potential role of endogenous bacteriophages in controlling invading pathogens[J]. Cell Mol Life Sci, 2005, 62(5):511-519.
|